Accelerated Epigenetic Ageing in Diabetic Kidney Disease: A Comparison of 10 Epigenetic Clock Measures in Individuals With Type 1 Diabetes



To characterize accelerated epigenetic ageing in individuals with diabetic kidney disease (DKD) and type 1 diabetes, 10 epigenetic clocks were generated for those with type 1 diabetes, with (case patients) or without (control participants) DKD, within the All Ireland–Warren 3–Genetics of Kidneys in Diabetes UK and Belfast Renal Transplant (UK-RoI; n = 464) and Finnish Diabetic Nephropathy (FinnDiane; n = 795) cohorts. Experimentally derived and epigenetically predicted telomere lengths (TLs) were also compared. This study revealed that higher PhenoAge and shorter epigenetically predicted TL were associated with increased DKD risk (principal component [PC] with z score version (zPC) of PhenoAge: odds ratio [OR] 1.4 [95% CI 1.2–1.8]; P = 2.47 × 10−4 in UK-ROI and OR 1.8 [95% CI 1.5–2.1]; P = 2.30 × 10−12 in FinnDiane; zPC–DNA methylation TL: OR 0.6 [95% CI 0.5–0.8]; P = 7.28 × 10−6 in UK-ROI and OR 0.7 [95% CI 0.6–0.8]; P = 1.40 × 10−6 in FinnDiane); age, white cell proportion, and sex adjusted). Case patients were epigenetically older than control participants by ∼2 years (PC-PhenoAge). Results suggested a male-specific association between DunedinPACE–epigenetic age acceleration (EAA) and DKD (OR 1.3 [95% CI 1.0–1.7]; P = 0.026 in UK-ROI and OR 1.5 [95% CI 1.3–1.8]; P = 1.46 × 10−6 in FinnDiane). Longitudinal analyses included 1) methylation at two time points a median of 7.5 years apart (n = 2 × 52) and 2) Cox regression for DKD progression in 384 case participants (median follow-up 7.7 years). Progression from normolbuminuria to severely increased albuminuria was associated with increased EAA. Chronologic age, epigenetic age, and EAA (PhenoAge-EAA P = 0.0011; hazard ratio 1.07 [95% CI 1.03–1.11] per year; C-index = 0.67) were significant predictors of progression to end-stage kidney disease (ESKD). Epigenetic biomarkers demonstrate accelerated biological ageing associated with DKD and progression to ESKD.

Article Highlights
  • We investigated whether an association existed between epigenetic age acceleration (EAA) and diabetic kidney disease (DKD) in type 1 diabetes, using 10 clocks and two cohorts, and whether this amplified disease progression.
  • Older EAA phenotypic age and shorter epigenetically predicted telomere lengths were significantly associated with DKD.
  • Progression from normolbuminuria to severely increased albuminuria was associated with increased EAA, and age, epigenetic age, and EAA were significant predictors of progression to end-stage kidney disease.
  • Results support the development of epigenetic biomarkers predicting DKD onset and progression.





Source link